complementary fluorescein‐and rhodamine‐labelled oligonucleotides (below) has been used to select peptide dsDNA binding ligands. A high structure–affinity relationship of the dsDNA‐binding unnatural peptide was observed.
Abstract
Combinatorial chemistry with a newly‐developed screening procedure using complementary fluorescein‐ and rhodamine‐labelled oligonucleotides (below) has been used to select peptide dsDNA binding ligands. A high structure–affinity relationship of the dsDNA‐binding unnatural peptide was observed.